Research

The mysterious path of HIV - from chimp to man and on to North America - is mysterious no longer

published: October, 25, 2011 Written by // Bob Leahy - Publisher Categories // Research, Features and Interviews, Bob Leahy - Publisher

Bob Leahy interviews the author of The Origins of AIDS, an exciting new book which reveals every link in the previously not well understood chain that saw the HIV virus travel from the jungles of Africa to North America.

The mysterious path of HIV - from chimp to man and on to North America - is mysterious no longer

I think it was someone getting the word out on twitter that first alerted me to the fact there was a new book out called The Origins of AIDS. Not only, we heard, was it a well documented account of the most likely way in which the virus spread – the circuitous route from chimp to man to worldwide epidemic – but it was also a page turner. The New York Time had written a fascinating account of its thesis which sparked my interest further. So I contacted its author, Dr Jacques Pepin, who

Reliving our victories

published: September, 29, 2011 Written by // Bob Leahy - Publisher Categories // Research, Health, Bob Leahy - Publisher

PositiveLite’s Brian Finch and Bob Leahy were both involved in the delivery of Ontario’s HIV Stigma.com campaign of 2008-9. Now the HIV prevention campaign’s findings have received international attention.

Reliving our victories

September 15, 2008 found me feeling rather lost and out of place in a dull-looking buidling, at least from the exterior, but which housed an impressively professional looking movie studio.  We were in an industrial area of East York (Toronto). I was there to film an interview for Top Drawer Creative, the ad agency GMSH (Gay Men’s Sexual Health Alliance) had engaged to produce the campaign for us. It was an intimidating set-up. Real lights, drapes, BIG cameras, sound

LATE BREAKER! ART at 350 -550 CD4 cuts disease rate 40%

published: July, 19, 2011 Categories // International AIDS Conference , Research, Brian Finch

LATE BREAKER! ART at 350 -550 CD4 cuts disease rate 40% in Randomized HPTN 052 Trail.

LATE BREAKER! ART at 350 -550 CD4 cuts disease rate 40%

ART at 350-550 CD4s Cuts Disease Rate 40% in Randomized HPTN 052 Trial 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 17-20, 2011, Rome Mark Mascolini Starting antiretroviral therapy (ART) at a CD4 count of 350 to 550 rather than waiting for a count of 250 lowered the risk of serious complications, especially extrapulmonary tuberculosis, by 40% in the randomized HPTN 052 trial, conducted in 5 African countries, Brazil, India, Thailand, and the United States [1]. Earlier

IAS Rome 2011 - Starting Treatment - a discussion with Dr Steven Deeks

published: July, 19, 2011 Written by // Brian Finch - Founder Categories // International AIDS Conference , Events, Features and Interviews, Research, Treatment, Brian Finch

My first interview at the Rome IAS conference with Dr. Steven Deeks.

IAS Rome 2011 - Starting Treatment - a discussion with Dr Steven Deeks

My first days at the conference have been frustrating, and to be frank, there is not a lot of news coming out on the topic I'm interested in, and not really so much that would be interesting to the community.  Much of the information coming out I'm going to have to sift through once I am back home to properly analyse.  Thiere is much emphasis on treatment as prevention, hard core drug studies that are difficult to understand, and very few presentations that play to the needs of

DEBI does Montréal

published: March, 09, 2011 Categories // Gay Men, Research

Ken Monteith reports that AIDS Community Care Montreal (ACCM) has embarked on an innovative strategy to encourage HIV testing among gay men. It's called the ATOMc Project.

DEBI does Montréal

The ATOMcproject trains volunteers in techniques to recruit gay men from their social circles to encourage them to be tested, and the project is currently recruiting volunteers. (I’ll explain DEBI later on.) Allow me to let the project’s promotional video explain the project: (see first video below).  There is general recognition in the HIV movement that knowing one’s status is key to maintaining one’s own health and in raising awareness to prevent transmission to others. The prob

Dr. Curtis Cooper & Greg Robinson on HIV/Hep coinfection and liver transplants

published: May, 16, 2010 Written by // Brian Finch - Founder Categories // Community Events, Hep B and C, Events, Features and Interviews, Research, Brian Finch

I'm reposting as to be able to publish links on Facebook. June 14th, at the Coutyard Marriot, the Canadian Treatment Action Council held a presentation and panel discussion on the latest litterature review and analysis on liver transplants for those who are either HIV or Hep B/C positive, or both. For those who may not know, if one is HIV + they are not able to get a transplant in Canada, nor will any of the provinces pay to have it done in the states. This is the first in an ongoing series to

<<  26 27 28 29 30 [31